AltaThera Pharmaceuticals Overview

  • Founded
  • 2012
  • Status
  • Private
  • Employees
  • 12
  • Latest Deal Type
  • Angel
  • Latest Deal Amount
  • $1.53M
Latest Deal Amount
  • Investors
  • 1

AltaThera Pharmaceuticals General Information


Provider of specialty pharmaceuticals intended to serve pediatric cardiac patients and adult Atrial Fibrillation patients with effective treatments. The company's product focuses on critical care and alternative therapeutics for unmet medical needs, enabling medical organizations to use effective treatment for severe disorders and improve patient's lives.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Primary Industry
Primary Office
  • 311 South Wacker Drive
  • Suite 2275A
  • Chicago, IL 60606
  • United States
+1 (312) 000-0000

AltaThera Pharmaceuticals Timeline

Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

AltaThera Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Angel (individual) 21-Aug-2019 $1.53M 00.000 Completed Generating Revenue
4. Angel (individual) 22-Dec-2016 00.000 00.000 Completed Generating Revenue
3. Angel (individual) 31-Jul-2015 000 00.00 Completed Generating Revenue
2. Angel (individual) 03-Feb-2015 $1.5M $1.5M Completed Generating Revenue
1. Accelerator/Incubator 28-Oct-2014 Completed Generating Revenue
To view AltaThera Pharmaceuticals’s complete valuation and funding history, request access »

AltaThera Pharmaceuticals Comparisons

HQ Location
Total Raised
Post Valuation
Last Financing Details
Provider of specialty pharmaceuticals intended to serve pediatric cardiac patients and adult Atrial Fibrillation patient
Chicago, IL
12 As of 2019
0000000000 00.000


Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatu
0000 000000000
Stevenage, United Kingdom
00.00 0000-00-00
00000000000 000.00


unt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco lab
Sunnyvale, CA
00 As of 0000
0000000000 00.000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

AltaThera Pharmaceuticals Competitors (8)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Gyroscope (Drug Discovery) Venture Capital-Backed Stevenage, United Kingdom 000.00 00000000000 000.00
00000000 Venture Capital-Backed Sunnyvale, CA 00 00.000 0000000000 00.000
0000000 0000000000 Formerly VC-backed Dallas, TX 00 00000 000000&0 00000
0000000000 Corporate Backed or Acquired Basel, Switzerland 000000&0
0000000 Venture Capital-Backed Newhouse, United Kingdom 00 000.00 0000000000 0 000.00
You’re viewing 5 of 8 competitors. Get the full list »

AltaThera Pharmaceuticals Executive Team (3)

Name Title Board Seat Contact Info
Jodi Devlin Chief Executive Officer
Brandon Kashfian Founder & Chief Business Officer
Stephen O'Sullivan JD Director, Chief Compliance Officer & General Counsel
To view AltaThera Pharmaceuticals’s complete executive team members history, request access »

AltaThera Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

AltaThera Pharmaceuticals Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Matter Ventures Accelerator/Incubator Minority 000 0000 000000 0
To view AltaThera Pharmaceuticals’s complete investors history, request access »